What is the usual volume of the next dose of allergy shot if a patient received 1ml last week and 0.7ml the week before?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Allergy Immunotherapy Dosing Protocol

The next dose of allergy immunotherapy should be 1.2 ml, following the standard incremental increase pattern from the previous doses of 0.7 ml and 1.0 ml. 1, 2

Rationale for Dose Progression

Allergen immunotherapy follows a build-up phase where doses are gradually increased until reaching maintenance levels. The standard approach involves:

  • Conventional build-up schedules typically increase doses by approximately 0.2-0.3 ml per injection when progressing through higher concentrations 1
  • The pattern observed (0.7 ml → 1.0 ml → next dose) shows a 0.3 ml increase in the previous step
  • Continuing this pattern, the next logical dose would be 1.2 ml 2

Key Considerations for Dose Progression

Standard Build-up Protocol

  • During the build-up phase, injections are typically administered 1-2 times per week 1
  • The volume generally increases at a rate that depends on:
    • Patient's sensitivity to the extract
    • History of prior reactions
    • Concentration being delivered (smaller percentage increments at higher concentrations) 1

Safety Factors

  • The progression from 0.7 ml to 1.0 ml (a 0.3 ml increase) was well tolerated as evidenced by the patient returning for subsequent dosing
  • Maintaining consistent incremental increases helps minimize risk of systemic reactions 1
  • Smaller percentage increases are recommended at higher concentrations 2

Potential Adjustments to Consider

While 1.2 ml is the recommended next dose, certain circumstances might warrant dose adjustments:

  • Prolonged interval between injections: If more than 1-2 weeks have elapsed since the last injection, dose reduction might be necessary 1
  • Recent systemic reactions: Would require dose reduction to previously tolerated levels 1
  • High allergen exposure periods: During peak allergen seasons for highly sensitive patients, consider not increasing or even reducing the dose 1, 2

Practical Implementation

  1. Administer 1.2 ml of the same concentration as the previous injection
  2. Observe patient for at least 30 minutes after injection to monitor for any adverse reactions
  3. Document the dose, patient's response, and any local or systemic reactions
  4. Plan subsequent dose increases based on tolerance to the current dose

Common Pitfalls to Avoid

  • Inconsistent increments: Erratic dose increases can increase risk of adverse reactions
  • Failure to adjust for missed appointments: If the interval between injections is prolonged, dose reduction is typically necessary 1
  • Ignoring seasonal factors: High allergen exposure periods may require more conservative dosing 2
  • Overlooking patient-specific factors: Individual sensitivity and previous reaction history should inform dosing decisions 1

Following this systematic approach to allergen immunotherapy dosing helps maximize efficacy while maintaining patient safety.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Immunotherapy and Treatment Protocols

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How can the medication regimen be optimized for a patient with depression, anxiety, Attention Deficit Hyperactivity Disorder (ADHD), and insomnia, currently taking sertraline (Zoloft) 150mg daily, lurasidone (Latuda) 40mg daily, bupropion (Wellbutrin) HCl 100mg daily, Adderall (dextroamphetamine and amphetamine) 10mg twice a day (BID), and hydroxyzine (Vistaril) 25mg BID as needed (PRN)?
What is the next best step for a 26-year-old female patient with uncontrolled essential hypertension on amlodipine (calcium channel blocker) 10mg daily and metoprolol (beta blocker) 50mg daily, with a blood pressure of 146/90 mmHg?
What is the next step in managing a patient with a history of normal myocardial perfusion study, normal ejection fraction (EF) between 65-70%, mild left ventricular hypertrophy (LVH), impaired relaxation filling pattern, mild aortic valve calcification, and moderate mitral valve calcification, who presents with shortness of breath, 1+ to 2+ pitting edema, and is currently on Furosemide (Lasix) 20 milligrams (mg) daily?
What is the best management approach for a 400-pound patient with severe lower back pain, degeneration, and herniated disc after a traumatic back injury?
What is the recommended initial dose and titration of Adderall (amphetamine and dextroamphetamine) for a patient?
What is the appropriate workup and treatment for a patient with a family history of recent typhoid infection presenting with intermittent fever (night spikes)?
What to do if a patient on levothyroxine (thyroid hormone replacement medication) has a low Thyroid-Stimulating Hormone (TSH) level?
What is the recommended treatment for insomnia in a patient with bipolar disorder, considering the use of trazodone (antidepressant)?
What is the treatment for ptosis (eyelid drop) after Botox (botulinum toxin) injections?
What are the recommended treatments for insomnia in patients with bipolar disorder?
Is Risperidone (antipsychotic medication) available as a subcutaneous formulation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.